Skip to content
Clinical trial

A multicenter, prospective, phase 2 trial on proton re‐irradiation for patients with previously treated head and neck cancer

Oct 2026 · Cancer · Vol 132 · 0 citations · 42 references
Medicine

Abstract

Re‐irradiation (re‐RT) for recurrent head and neck cancer (HNC) can be potentially curative but is constrained by significant toxicity. Proton therapy may improve the therapeutic ratio. This multicenter phase 2 trial evaluated the safety and efficacy of proton re‐RT in patients with HNC.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.